Logo video2dn
  • Сохранить видео с ютуба
  • Категории
    • Музыка
    • Кино и Анимация
    • Автомобили
    • Животные
    • Спорт
    • Путешествия
    • Игры
    • Люди и Блоги
    • Юмор
    • Развлечения
    • Новости и Политика
    • Howto и Стиль
    • Diy своими руками
    • Образование
    • Наука и Технологии
    • Некоммерческие Организации
  • О сайте

Видео ютуба по тегу Dr. Alex Spyropoulos

Clot Chronicles: Dr. Spyropoulos Discusses an IMPROVE-DD Venous Case Study
Clot Chronicles: Dr. Spyropoulos Discusses an IMPROVE-DD Venous Case Study
Subspecialty Lecture:  Antithrombosis and COVID-19 with Dr. Alex Spyropoulos
Subspecialty Lecture: Antithrombosis and COVID-19 with Dr. Alex Spyropoulos
Duration of Anticoagulation Therapy and Patient Outcomes
Duration of Anticoagulation Therapy and Patient Outcomes
ESC 2018: MARINER - Prof Alex Spyropoulos
ESC 2018: MARINER - Prof Alex Spyropoulos
Alex Spyropoulos, Professor of Medicine, the Zucker School of Medicine at Hofstra/Northwell, USA
Alex Spyropoulos, Professor of Medicine, the Zucker School of Medicine at Hofstra/Northwell, USA
Minimizing the risk of thromboembolic disease in HIV infection
Minimizing the risk of thromboembolic disease in HIV infection
Predicting Risk of Bleeding in Medical Patients
Predicting Risk of Bleeding in Medical Patients
Alex C. Spyropoulos, MD, FACP, FCCP, Highlights Recent VTE Updates (Part 1)
Alex C. Spyropoulos, MD, FACP, FCCP, Highlights Recent VTE Updates (Part 1)
728: Researching Risk Factors and Therapies for Blood Clots in the Lungs and Legs - Dr. Alex Spyr...
728: Researching Risk Factors and Therapies for Blood Clots in the Lungs and Legs - Dr. Alex Spyr...
HEP-COVID Clinical Trial Results on the Prevention of Blood Clots
HEP-COVID Clinical Trial Results on the Prevention of Blood Clots
Screening for thromboembolic disease in HIV
Screening for thromboembolic disease in HIV
Alex C. Spyropoulos, MD, FACP, FCCP, Highlights Recent VTE Updates (Part 2)
Alex C. Spyropoulos, MD, FACP, FCCP, Highlights Recent VTE Updates (Part 2)
Anticoagulant care in patients with VTE
Anticoagulant care in patients with VTE
Clot Chronicles: Thrombotic Risk and Anticoagulation Benefits in Discharged COVID-19 Patients
Clot Chronicles: Thrombotic Risk and Anticoagulation Benefits in Discharged COVID-19 Patients
CommonSpirit Health Grand Rounds/Clinical Update: COVID-19 Thrombotic Complications
CommonSpirit Health Grand Rounds/Clinical Update: COVID-19 Thrombotic Complications
What Is The Risk Of Having Another Blood Clot?
What Is The Risk Of Having Another Blood Clot?
Clot Chronicles: Key Findings from the HEP-COVID Trial
Clot Chronicles: Key Findings from the HEP-COVID Trial
National Blood Clot Alliance Stop the Clot Channel
National Blood Clot Alliance Stop the Clot Channel
ESC: Rivaroxaban Doesn't Prevent VTE after Acute Illness - Medpage Today
ESC: Rivaroxaban Doesn't Prevent VTE after Acute Illness - Medpage Today
Следующая страница»
  • О нас
  • Контакты
  • Отказ от ответственности - Disclaimer
  • Условия использования сайта - TOS
  • Политика конфиденциальности

video2dn Copyright © 2023 - 2025

Контакты для правообладателей [email protected]